Steris Plc (STE) Return on Investment ROI from the fourth quarter of 2026 to fourth quarter of 2025 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Steris Plc  (NYSE: STE)


Steris Plc's ROI from its fourth quarter of 2026 to the fourth quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Steris Plc's ROI in the fourth quarter of 2026?
Steris Plc achieved a return on average invested assets (ROI) of 8.31 % in its fourth quarter of 2026, this is above STE's average return on investment of 5.79%.
Steris Plcs investments during the 12 months ending in the fourth quarter of 2026 are valued at $9 billion

ROI has improved compared to 7.62% in the third quarter of 2026, due to net income growth.

Within the Healthcare sector 130 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2026 from 948 to 1086.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
IV. Quarter		 (Dec 31 2025)
III. Quarter		 (Sep 30 2025)
II. Quarter		 (Jun 30 2025)
I. Quarter		 (Mar 31 2025)
IV. Quarter
Y / Y Investment Change TTM -0.68 % -4.44 % -1.41 % -4.01 % -5.97 %
Y / Y Net Income Change TTM 27.44 % 51.57 % 133.29 % 348.69 % -
Investment (TTM) in Millions 9,606 9,137 9,535 9,491 9,139
Return On Investment (TTM) 8.31 % 7.62 % 7.2 % 6.79 % 6.48 %
STE's Overall Ranking # 1086 # 948 # 1002 # 960 # 1050
Seq. Investment Change TTM 1.25 % -2.63 % 0.21 % 0.53 % -2.58 %
Seq. Net Income Change TTM 10.44 % 3.05 % 6.37 % 5.27 % 31.36 %
Net Income (TTM) in Millions 785 711 690 649 616

STE Company Profile >> Back to STE Roi Comparisons >> See Annual STE Return On Investment



Return On Investment STE's Ranking
Within: No.
Industry # 39
Sector # 131
Overall # 1086

Return On Investment Statistics
High Average Low
12.59 %
5.79 %
-1.02 %
(Jun 30 2011)  







Financial Statements
Steris Plc's IV. Quarter Investments $ 9,606 Millions STE's Balance sheet
Steris Plc's IV. Quarter Income $ 220 Millions Quarterly STE's Income Statement
STE's Income by Division See STE's Income by Division


STE Annual Return On Investment (Mar 31 2026)
2026		 (Mar 31 2025)
2025		 (Mar 31 2024)
2024		 (Mar 31 2023)
2023		 (Mar 31 2018)
2018
Total Investments in Millions 9,606 9,137 10,146 9,970 4,811
Y / Y Investment Growth 5.13 % -9.94 % 1.76 % 107.21 % 5.65 %
Net Income in Millions 785 616 380 106 292
Y / Y Net Income Growth 27.44 % 62.09 % 259.2 % -63.72 % 163.6 %
Annual Return On Investment 8.17 % 6.74 % 3.75 % 1.06 % 6.06 %


Annual Roi Comment
In the fiscal year 2026 ROI improved to 8.17 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
STE's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for STE's Competitors
Subscribers only: Roi for Steris Plc's Suppliers
Subscribers only: Return On Investment for STE's Customers

Other Ratios
STE's Roa STE's Inventory Turnover Ratio STE's Growth Rates STE's Dividend Statistics
STE's Profitability Ratios STE's Asset Turnover Ratio STE's Dividend Growth
STE's Roe STE's Valuation Ratios STE's Financial Strength Ratios STE's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI
Engene Therapeutics Inc   22.76 %
Protalix Biotherapeutics inc   22.70 %
Electromed Inc   22.36 %
Dexcom Inc   22.17 %
Illumina Inc   22.01 %
Pro dex Inc   20.88 %
Gilead Sciences Inc   20.52 %
Vertex Pharmaceuticals Inc  20.49 %
Agilent Technologies inc   20.46 %
Zoetis Inc   20.35 %
Resmed Inc   20.23 %
Soleno Therapeutics Inc  19.51 %
Krystal Biotech Inc   19.07 %
Puma Biotechnology Inc   18.83 %
United Therapeutics Corporation  18.64 %
Hca Healthcare Inc   18.54 %
Chemed Corporation  18.36 %
Apellis Pharmaceuticals Inc   17.94 %
Neurocrine Biosciences Inc   17.65 %
Halozyme Therapeutics Inc   17.53 %
Transmedics Group Inc   17.09 %
Inspire Medical Systems inc   16.60 %
Aveanna Healthcare Holdings Inc   16.38 %
Intuitive Surgical Inc   16.36 %
Alnylam Pharmaceuticals Inc   16.15 %
Strata Critical Medical Inc   16.15 %
Standard Biotools Inc   15.94 %
Profound Medical Corp   15.18 %
West Pharmaceutical Services Inc   14.67 %
Embecta Corp   14.58 %

Date modified: 2026-08-14T21:16:43+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.